Synthesis of a novel C46 ceramide and its skin barrier repair effect verified by molecular dynamics and cellular assays
Rattachement africain : cn. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Objective Ceramides play a critical role in skin barrier function. Here, we synthesized a novel long-chain ceramide, C46 EOP, via a sustainable catalyst-free route and elucidated its molecular mechanisms and barrier repair efficacy using an integrated computational-experimental strategy. Methods A novel C46 long-chain ceramide EOP was synthesized via a sustainable catalyst-free two-step cascade route, achieving purity exceeding 98.5%. To elucidate its mechanism of action, molecular docking and molecular dynamics simulations were employed to predict the binding modes and stability of EOP with key skin barrier targets (IL-6, AQP3, ELANE), supported by thermodynamic free energy calculations. The functional outcomes of EOP were experimentally verified by assessing cell viability (MTT), migration, and gene/protein expression (RT-qPCR, ELISA). Results Molecular docking and molecular dynamic simulation identified stable EOP binding to key targets of skin barrier: IL-6 (ΔG = −5.393 kcal/mol), AQP3 (ΔG = −5.300 kcal/mol), and ELANE (ΔG = −5.543 kcal/mol). In vitro assays demonstrated concentration-dependent inhibition of elastase activity, reaching 34.78% at 772 mg/L. EOP treatment significantly suppressed IL-6 mRNA expression by 89% at 772 mg/L and reduced IL-6 protein levels by 56.83% at 123.52 mg/L. Furthermore, EOP markedly upregulated AQP3 mRNA expression by 42.34% at 1235.2 mg/L and increased AQP3 protein expression by 129% at 123.52 mg/L. Conclusion This integrated computational-experimental approach validates the multi-target efficacy of the novel synthetic C46 ceramide EOP in skin barrier repair at both molecular and cellular levels. The work deepens the mechanistic understanding of long-chain ceramides and provides a rational strategy for the development of novel dermatological actives.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Synthesis of a novel C46 ceramide and its skin barrier repair effect verified by molecular dynamics and cellular assays
- Date Crossref
- 01/03/2026
- Éditeur
- Elsevier BV
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Guangdong Pharmaceutical University pays non établi dans la noticeUniversité ou école supérieure
-
Beike Biotechnology (China) pays non établi dans la noticeEntreprise
-
Beijing Chaoyang Emergency Medical Center pays non établi dans la noticeÉtablissement de santé
-
School of Chemistry and Chemical Engineering pays non établi dans la noticeUniversité ou école supérieure
-
Ltd. Shenzhen Dieckmann Biotechnology Co. pays non établi dans la noticeEntreprise
-
Medicines and Equipment Department pays non établi dans la noticeInstitution
Guangdong Pharmaceutical University, Beike Biotechnology (China) et Beijing Chaoyang Emergency Medical Center, avec 3 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.